Literature DB >> 849767

Schistosoma mansoni: kinetics and class specificity of hypergammaglobulinemia induced during murine infection.

A Sher, S McIntyre, F von Lichtenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 849767     DOI： 10.1016/0014-4894(77)90114-x

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN： 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  7 in total

1.  Schistosoma mansoni: analysis of monoclonal antibodies reactive with gut-associated antigens.

Authors:  G J van Dam; D Kornelis; R J Van Zeyl; J P Rotmans; A M Deelder
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 2.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

3.  Schistosoma mansoni: autoantibodies and polyclonal B cell activation in infected mice.

Authors:  E Fischer; D Camus; F Santoro; A Capron
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

4.  Secondary amyloidosis in normal and immunocompromised mice infected with Schistosoma japonicum.

Authors:  A J Luty; C D Mackenzie; N A Moloney
Journal:  Br J Exp Pathol       Date:  1987-12

5.  Serum protein concentrations during Schistosoma mansoni infection in intact and T-cell deprived mice. II. Immunoglobulin G and antibodies specific for heterologous erythrocytes.

Authors:  R Musallam; J Bain; A McGregor; M Doenhoff
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

6.  IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease.

Authors:  Keke C Fairfax; Eyal Amiel; Irah L King; Tori C Freitas; Markus Mohrs; Edward J Pearce
Journal:  PLoS Pathog       Date:  2012-01-26       Impact factor: 6.823

7.  CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling.

Authors:  D Jankovic; A W Cheever; M C Kullberg; T A Wynn; G Yap; P Caspar; F A Lewis; R Clynes; J V Ravetch; A Sher
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.